Stock 605199 HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hainan Huluwa Pharmaceutical Group Co., Ltd.

Equities

605199

CNE100004223

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 06/06/2024 BST 		5-day change 1st Jan Change
10.33 CNY +1.97% Intraday chart for Hainan Huluwa Pharmaceutical Group Co., Ltd. -6.77% -31.86%
05-01 Huluwa Pharmaceutical Gets Nod to Register Two Drugs MT
04-26 Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Hainan Huluwa Pharmaceutical Group Co Ltd is a China-based company principally involved in the research and development, manufacturing and sales of Chinese patent medicines and chemical drugs. Its products are used in the pharmaceutical fields of respiratory system, digestive system, systemic anti-infection, including pediatric lung heat cough asthma granules, bromhexine hydrochloride for injection, compound Banlangen granules, Keke tablets, omeprazole enteric-coated capsules , Changyanning (capsules and granules), omeprazole sodium for injection, sodium diisopropylamine dichloroacetate for injection and cefixime dispersible tablets, among others. The Company also provides gynecological medicine, cardiovascular system medicine and neurological system medicine preparation products. The Company operates its businesses in the domestic market.

Number of employees: 2,468

Sales per Business

CNY in Million2022Weight2023Weight Delta
Respiratory Medicine
59.9 %
933 61.6 % 1,140 59.9 % +22.26%
Digestive System Medicine
21.0 %
362 23.9 % 400 21.0 % +10.50%
Other Drugs
11.4 %
92 6.1 % 218 11.4 % +135.87%
Systemic Anti-infective Drugs
7.7 %
128 8.4 % 147 7.7 % +14.75%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,515 100.0 % 1,905 100.0 % +25.75%

Managers

Managers TitleAgeSince
Jing Ping Liu CEO
 Chief Executive Officer 54 30/11/07
Peng Xu CHM
 Chairman 61 28/02/10
Hui Yu DFI
 Director of Finance/CFO 40 07/07/22
Jun Ling Li BRD
 Director/Board Member 56 31/08/18
Bao Kun Wan BRD
 Director/Board Member 62 31/03/12
Ping Liu BRD
 Director/Board Member 51 29/02/12
Hai Yan Wang IRC
 Investor Relations Contact 37 29/02/20
Qing Tao Wang SEC
 Corporate Secretary 42 28/02/15

Members of the board

Members of the board TitleAgeSince
Gui Hua Wang BRD
 Director/Board Member 63 15/11/18
Jing Ping Liu CEO
 Chief Executive Officer 54 30/11/07
Ping Liu BRD
 Director/Board Member 51 29/02/12
Bao Kun Wan BRD
 Director/Board Member 62 31/03/12
Hui Yu DFI
 Director of Finance/CFO 40 07/07/22
Jun Ling Li BRD
 Director/Board Member 56 31/08/18
Qi Bo Tang BRD
 Director/Board Member 36 03/11/22
Shi Xian Wang BRD
 Director/Board Member 48 03/11/22
Qiu Yun Liu BRD
 Director/Board Member 45 03/11/22
Peng Xu CHM
 Chairman 61 28/02/10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 400,108,752 83,526,717 ( 20.88 %) 0 20.88 %

Shareholders

NameEquities%Valuation
Jing Ping Liu
41.76 %
167,079,000 41.76 % 270 M ¥
Jin Hua Lu
19.26 %
77,075,460 19.26 % 124 M ¥
Xu Dong Tang
10.95 %
43,824,000 10.95 % 71 M ¥
Jie Cheng Tang
4.696 %
18,789,540 4.696 % 30 M ¥
Penghua Fund Management Co., Ltd.
0.0436 %
174,526 0.0436 % 281 739 ¥
China Southern Asset Management Co., Ltd.
0.0433 %
173,300 0.0433 % 279 760 ¥
Shanghai Guotai Junan Securities Assets Management Co., Ltd.
0.0171 %
68,300 0.0171 % 110 257 ¥
Huatai-PineBridge Fund Management Co., Ltd.
0.009698 %
38,803 0.009698 % 62 640 ¥
Yinhua Fund Management Co., Ltd.
0.004074 %
16,300 0.004074 % 26 313 ¥
Fullgoal Fund Management Co., Ltd.
0.003049 %
12,200 0.003049 % 19 695 ¥

Company contact information

Hainan Huluwa Pharmaceutical Group Co., Ltd.

8, Yaogu 4th Road Phase II, Yaogu Industrial Park

570311, Haikou

+

http://www.huluwayaoye.com
address Hainan Huluwa Pharmaceutical Group Co., Ltd.(605199)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD. Stock Hainan Huluwa Pharmaceutical Group Co., Ltd.
-31.86% 559M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+46.01% 754B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.95% 630B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.67% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.93% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.43% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.45% 250B
NOVARTIS AG Stock Novartis AG
+11.88% 217B
ROCHE HOLDING AG Stock Roche Holding AG
-0.78% 216B
AMGEN INC. Stock Amgen Inc.
+6.37% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 605199 Stock
  4. Company Hainan Huluwa Pharmaceutical Group Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW